Let F/F0 be a quadratic extension of non-archimedean locally compact fields of residue characteristic p = 2. Let R be an algebraically closed field of characteristic different from p. For π a supercuspidal representation of G = GLn(F ) over R and G τ a unitary group in n variables contained in G, we prove that π is distinguished by G τ if and only if π is Galois invariant. When R = C and F is a p-adic field, this result first as a conjecture proposed by Jacquet was proved in 2010's by Feigon-Lapid-Offen by using global method. Our proof is local which works for both complex case and l-modular case with l = p. We further study the dimension of HomGτ (π, 1) and show that it is at most one.
Let F be a non-archimedean locally compact field of residue characteristic p = 2, let G = GLn(F ) and let H be an orthogonal subgroup of G. For π a complex smooth supercuspidal representation of G, we give a full characterization for the distinguished space HomH(π, 1) being non-zero and we further study its dimension as a complex vector space, which generalizes a similar result of Hakim for tame supercuspidal representations. As a corollary, the embeddings of π in the space of smooth functions on the set of symmetric matrices in G, as a complex vector space, is non-zero and of dimension four, if and only if the central character of π evaluating at −1 is 1.
Let F be a non-archimedean local field. The classification of the irreducible representations of GLn(F ), n ≥ 0 in terms of supercuspidal representations is one of the highlights of the Bernstein-Zelevinsky theory. We give an analogous classification for metaplectic coverings of GLn(F ), n ≥ 0.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.